about
Neurological approaches for investigating West Nile virus disease and its treatment in rodentsDefining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster ModelEffect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster modelAxonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysisC3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infectionWest Nile virus–induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neuronsEfficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodentsPersistent West Nile Virus Associated with a Neurological Sequela in Hamsters Identified by Motor Unit Number EstimationRift Valley fever virus infection in golden Syrian hamstersEfficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model.Fatal neurological respiratory insufficiency is common among viral encephalitidesNeurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus.Autonomic nervous dysfunction in hamsters infected with West Nile virus.Inhibition of West Nile virus by calbindin-D28k.Respiratory insufficiency correlated strongly with mortality of rodents infected with West Nile virus.West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters.An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibodyAutonomic deficit not the cause of death in West Nile virus neurological diseasePhrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters.Zika virus infection of adult and fetal STAT2 knock-out hamsters.Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1.Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents.Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.Human astrocytes/astrocyte-conditioned medium and shear stress enhance the barrier properties of human brain microvascular endothelial cells.Divergent effects of zinc depletion in brain vs non-brain endothelial cells.Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering.Comparative Histopathologic Lesions of the Male Reproductive Tract during Acute Infection of Zika Virus in AG129 and IFNAR-/- Mice.Causation of Acute Flaccid Paralysis by Myelitis and Myositis in Enterovirus-D68 Infected Mice Deficient in Interferon αβ/γ Receptor Deficient Mice.Small-Animal Models of Zika Virus.Zika virus-induced acute myelitis and motor deficits in adult interferon αβ/γ receptor knockout mice.Consequences of in utero exposure to Zika virus in offspring of AG129 mice.
P50
Q27009096-4BF5A813-C370-429B-AB35-9D93EF64E008Q27480795-3CC3F9FC-14F8-4941-B087-B30AC07ACBFEQ27481327-04C4AC3C-3737-4DC2-9177-ED1044A33C2DQ27481332-E211AC05-576C-45E5-95D6-00CCB8201CB8Q27486152-354C786E-6B67-49B2-A88D-DE8D6BFFB1A5Q27487333-53A2EE8E-625D-4CFF-9139-D379A2083B88Q27487357-F7D9C254-18C2-46AB-8388-B50B6A5C0D94Q27488303-9D713E29-032F-4958-9915-5E1387FE59AFQ28543047-D287863C-E6E7-42DB-8959-CCB240B0B138Q30395163-457403B8-1CD1-400C-832F-71641D2089ACQ30418122-F9A2A1FA-E6F3-409B-A18B-73DC7EAE99CFQ30474961-C01FF3A9-FC64-4D70-B862-E51CB81E1F28Q33900339-F68F9E5A-400F-49B4-936C-44877E5658FEQ34122546-94CF84E5-DC67-474F-A89B-CB5B0DCFBF8AQ34311960-6CB97CED-9A84-4E83-B0B9-5454F6DFA03BQ35016305-67CC159B-75D0-4DBE-9A31-3AEA85F745CEQ37123147-88C2612F-95D5-4A05-AA84-5C88DCF2074EQ37568909-8026E4A3-1081-423C-AEB4-CFC6C80C7F3EQ37675696-36750B5A-91EA-4D77-9150-E57A02F68C05Q40047447-FC99EAA9-F512-4386-A0B8-E3A13E3406C6Q40325658-7CEBD173-E4F6-4DB0-92C5-429A7671B231Q40429436-F1E18153-340B-4340-8630-08F470E403E2Q40467368-97849587-7441-4BD7-8BFC-E25F52DD5EE5Q43116931-2FD51D93-8B51-45EE-BF53-7F727A46DBA9Q43572747-5E398A8C-41D5-46C2-8D3B-9D785984D7CDQ44119840-0D9657F6-AFCC-45C3-AECF-6980471CAE86Q47548252-1D36245B-BD94-4477-B754-85CE1538A17CQ47554374-022F2136-0AC6-49BC-8BEE-197637F64EACQ47558337-34BB0FBC-5797-4CF9-984E-6AF1ECC408B4Q51336662-6D96B291-CFF7-4713-BE16-A19165360516Q55491432-A5276B31-D6B1-44EE-A66D-582CC04143C8
P50
name
Venkatraman Siddharthan
@ast
Venkatraman Siddharthan
@en
Venkatraman Siddharthan
@es
Venkatraman Siddharthan
@nl
type
label
Venkatraman Siddharthan
@ast
Venkatraman Siddharthan
@en
Venkatraman Siddharthan
@es
Venkatraman Siddharthan
@nl
prefLabel
Venkatraman Siddharthan
@ast
Venkatraman Siddharthan
@en
Venkatraman Siddharthan
@es
Venkatraman Siddharthan
@nl